In this paper, we introduce a novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer’s Disease (AD) diagnosis and biomarker identification. Our method is an end-to-end approach that embeds an adversarial focal loss discriminator within the autoencoder structure, specifically designed to effectively target and capture more complex and challenging cases. We first use the enhanced autoencoder to create a normative model based on data from healthy control (HC) individuals. We then apply this model to estimate total and regional neuroanatomical deviation in AD patients. Through extensive experiments on the OASIS-3 and ADNI datasets, our approach significantly outperforms previous state-of-the-art methods. This advancement not only streamlines the detection process but also provides a greater insight into the biomarker potential for AD. Our code can be found at https://github.com/soz223/FAAE .

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Normative Modeling with Focal Loss and Adversarial Autoencoders for Alzheimer’s Disease Diagnosis and Biomarker Identification

  • Songlin Zhao,
  • Rong Zhou,
  • Yu Zhang,
  • Yong Chen,
  • Lifang He

摘要

In this paper, we introduce a novel normative modeling approach that incorporates focal loss and adversarial autoencoders (FAAE) for Alzheimer’s Disease (AD) diagnosis and biomarker identification. Our method is an end-to-end approach that embeds an adversarial focal loss discriminator within the autoencoder structure, specifically designed to effectively target and capture more complex and challenging cases. We first use the enhanced autoencoder to create a normative model based on data from healthy control (HC) individuals. We then apply this model to estimate total and regional neuroanatomical deviation in AD patients. Through extensive experiments on the OASIS-3 and ADNI datasets, our approach significantly outperforms previous state-of-the-art methods. This advancement not only streamlines the detection process but also provides a greater insight into the biomarker potential for AD. Our code can be found at https://github.com/soz223/FAAE .